SG11201502245RA - Novel phenylacetamide compound and pharmaceutical containing same - Google Patents
Novel phenylacetamide compound and pharmaceutical containing sameInfo
- Publication number
- SG11201502245RA SG11201502245RA SG11201502245RA SG11201502245RA SG11201502245RA SG 11201502245R A SG11201502245R A SG 11201502245RA SG 11201502245R A SG11201502245R A SG 11201502245RA SG 11201502245R A SG11201502245R A SG 11201502245RA SG 11201502245R A SG11201502245R A SG 11201502245RA
- Authority
- SG
- Singapore
- Prior art keywords
- containing same
- pharmaceutical containing
- phenylacetamide compound
- novel
- novel phenylacetamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012211623 | 2012-09-26 | ||
| PCT/JP2013/005657 WO2014050084A1 (en) | 2012-09-26 | 2013-09-25 | Novel phenylacetamide compound and pharmaceutical containing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201502245RA true SG11201502245RA (en) | 2015-05-28 |
Family
ID=50387521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201502245RA SG11201502245RA (en) | 2012-09-26 | 2013-09-25 | Novel phenylacetamide compound and pharmaceutical containing same |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9242978B2 (en) |
| EP (1) | EP2902390B1 (en) |
| JP (1) | JP6218736B2 (en) |
| KR (1) | KR20150064727A (en) |
| CN (1) | CN104662013A (en) |
| AU (1) | AU2013321961A1 (en) |
| BR (1) | BR112015005631A2 (en) |
| CA (1) | CA2883535A1 (en) |
| EA (1) | EA201590626A1 (en) |
| IL (1) | IL237781A0 (en) |
| MX (1) | MX2015003638A (en) |
| PH (1) | PH12015500589A1 (en) |
| SG (1) | SG11201502245RA (en) |
| TW (1) | TW201416359A (en) |
| WO (1) | WO2014050084A1 (en) |
| ZA (1) | ZA201500844B (en) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2744893A1 (en) | 2002-06-27 | 2004-01-08 | Novo Nordisk A/S | Aryl carbonyl derivatives as glucokinase activators |
| PL378117A1 (en) * | 2003-02-11 | 2006-03-06 | Prosidion Limited | Tri(cyclo) substituted amide compounds |
| EP1758611A2 (en) | 2004-06-17 | 2007-03-07 | Novo Nordisk A/S | Use of liver-selective glucokinase activators |
| JP2009514835A (en) * | 2005-11-03 | 2009-04-09 | プロシディオン・リミテッド | Tricyclo-substituted amide |
| US20080293741A1 (en) * | 2005-11-03 | 2008-11-27 | Matthew Colin Thor Fyfe | Tricyclo Substituted Amides as Glucokinase Modulators |
| EP2261216A3 (en) * | 2006-07-24 | 2011-12-14 | F. Hoffmann-La Roche AG | Pyrazoles as glucokinase activators |
| JP4328820B2 (en) * | 2007-01-10 | 2009-09-09 | 田辺三菱製薬株式会社 | Pharmaceutical composition |
| US8034819B2 (en) | 2007-03-07 | 2011-10-11 | Kyorin Pharmaceutical Co., Ltd. | Glucokinase activator |
| US8173645B2 (en) * | 2007-03-21 | 2012-05-08 | Takeda San Diego, Inc. | Glucokinase activators |
| EP2195304B1 (en) * | 2007-10-08 | 2014-01-08 | Advinus Therapeutics Private Limited | Acetamide derivatives as glucokinase activators, their process and medicinal applications |
-
2013
- 2013-09-25 EP EP13841117.8A patent/EP2902390B1/en active Active
- 2013-09-25 US US14/427,865 patent/US9242978B2/en not_active Expired - Fee Related
- 2013-09-25 KR KR1020157006089A patent/KR20150064727A/en not_active Application Discontinuation
- 2013-09-25 CA CA2883535A patent/CA2883535A1/en not_active Abandoned
- 2013-09-25 JP JP2014538176A patent/JP6218736B2/en not_active Expired - Fee Related
- 2013-09-25 SG SG11201502245RA patent/SG11201502245RA/en unknown
- 2013-09-25 AU AU2013321961A patent/AU2013321961A1/en not_active Abandoned
- 2013-09-25 EA EA201590626A patent/EA201590626A1/en unknown
- 2013-09-25 TW TW102134611A patent/TW201416359A/en unknown
- 2013-09-25 CN CN201380049197.1A patent/CN104662013A/en active Pending
- 2013-09-25 BR BR112015005631A patent/BR112015005631A2/en not_active IP Right Cessation
- 2013-09-25 WO PCT/JP2013/005657 patent/WO2014050084A1/en active Application Filing
- 2013-09-25 MX MX2015003638A patent/MX2015003638A/en unknown
-
2015
- 2015-02-05 ZA ZA2015/00844A patent/ZA201500844B/en unknown
- 2015-03-16 IL IL237781A patent/IL237781A0/en unknown
- 2015-03-18 PH PH12015500589A patent/PH12015500589A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20150218151A1 (en) | 2015-08-06 |
| EP2902390B1 (en) | 2019-04-24 |
| AU2013321961A1 (en) | 2015-03-05 |
| IL237781A0 (en) | 2015-05-31 |
| EA201590626A1 (en) | 2015-07-30 |
| US9242978B2 (en) | 2016-01-26 |
| KR20150064727A (en) | 2015-06-11 |
| PH12015500589A1 (en) | 2015-05-11 |
| CN104662013A (en) | 2015-05-27 |
| MX2015003638A (en) | 2015-06-05 |
| JP6218736B2 (en) | 2017-10-25 |
| ZA201500844B (en) | 2016-01-27 |
| JPWO2014050084A1 (en) | 2016-08-22 |
| TW201416359A (en) | 2014-05-01 |
| WO2014050084A1 (en) | 2014-04-03 |
| CA2883535A1 (en) | 2014-04-03 |
| EP2902390A4 (en) | 2016-03-09 |
| EP2902390A1 (en) | 2015-08-05 |
| BR112015005631A2 (en) | 2017-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274988A (en) | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use | |
| HK1215948A1 (en) | Amide compound and pharmaceutical application therefor | |
| EP2907802A4 (en) | Cyclopropanamine compound and use thereof | |
| HK1199839A1 (en) | Amido compounds as ror-gamma-tmodulators and uses thereof rort | |
| IL237309A0 (en) | Benzocyclooctyne compounds and uses thereof | |
| SG11201405578TA (en) | Pharmaceutical composition containing peptide | |
| EP2875014A4 (en) | Anti-mucus drugs and uses therefor | |
| HK1201270A1 (en) | Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides -5---5-- | |
| GB201217560D0 (en) | Novel cyclic depsipeptide compounds and their uses | |
| EP2837632A4 (en) | Compound jk12a and preparation thereof | |
| SG11201406942SA (en) | Trans-2-decenoic acid derivative and drug containing same | |
| HK1204945A1 (en) | Pharmaceutical formulation containing flupirtin | |
| IL237781A0 (en) | Novel phenylacetamide compound and pharmaceutical containing same | |
| GB201222342D0 (en) | Compounds and uses thereof | |
| GB201213726D0 (en) | Novel compounds and their use |